Heparanase in Primary Human Osteoblasts

Date

2010

Authors

Smith, Paul
Freeman, Craig
Yu, Di
Chen, Ming-Ming
Gatenby, Paul
Li, Rachel
Parish, Christopher

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Heparanase (HPSE) is known to be involved in fracture repair in mice, but its presence and function in human bone formation remains unclear. Our aim was to determine the expression of HPSE in human bone forming osteoblasts and to better understand its role in osteogenesis. HPSE protein expression and enzymatic activity were demonstrated in osteoblasts isolated from trabecular bone specimens of patients with osteoporosis (OP) and from healthy subjects, although the levels differed markedly. Thus, low levels of HPSE expression were observed in osteoporotic osteoblasts, including in the nucleus compared to those from healthy subjects. Notably, HPSE gene expression was associated with alkaline phosphatase (ALP) activity, the bone turnover marker. Gene profile studies demonstrated that osteogenic genes were downregulated in osteoporotic osteoblasts. We further exposed osteoblasts to exogenous HPSE and found that the level of histone H3 phosphorylation was increased. We provide evidence, for the first time, demonstrating that HPSE expresses and functions in human osteoblasts. Our data suggest that previously undescribed function of HPSE-mediated osteoblastogenesis through regulation of osteogenic gene expression and histone H3 modification. HPSE upregulation may be a novel therapeutic approach in the prevention and treatment of OP.

Description

Keywords

Keywords: alkaline phosphatase; heparanase; histone H3; adult; aged; article; bone development; bone turnover; cell structure; clinical article; controlled study; down regulation; enzyme activity; gene expression; human; human cell; osteoblast; osteoporosis; priori Extracellular matrix; Gene expression; Heparanase; Osteoblasts; Osteogenesis

Citation

Source

Journal of Orthopaedic Research

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

Restricted until

2037-12-31